Elevated Baseline Serum PD-L1 Level May Predict Poor Outcomes from Breast Cancer in African-American and Hispanic Women

Background: The therapeutic targeting of PD-1/PD-L1 has shown clinical efficacy in treating metastatic breast cancer. We investigated the clinical significance of measuring serum PD-L1 levels in African-American and Hispanic women with breast cancer. Methods: PD-L1 levels were measured with the ELIS...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yanyuan, Dutta, Pranabananda, Clayton, Sheilah, McCloud, Amaya, Vadgama, Jaydutt V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779890/
https://www.ncbi.nlm.nih.gov/pubmed/35053979
http://dx.doi.org/10.3390/jcm11020283

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779890/
https://www.ncbi.nlm.nih.gov/pubmed/35053979
http://dx.doi.org/10.3390/jcm11020283

Ejemplares similares